Brian Kearney - Feb 1, 2023 Form 4 Insider Report for PARDES BIOSCIENCES, INC. (PRDS)

Role
Chief Development Officer
Signature
/s/ Elizabeth Lacy, attorney-in-fact
Stock symbol
PRDS
Transactions as of
Feb 1, 2023
Transactions value $
$0
Form type
4
Date filed
2/3/2023, 03:30 PM
Previous filing
Sep 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRDS Stock Option (Right to Buy) Award $0 +156K $0.00 156K Feb 1, 2023 Common Stock 156K $2.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests over four years with 1/48th of the shares subject to such option vesting and becoming exercisable in substantially equal monthly installments on the 1st day of each month after the Grant Date (02/01/2023), subject to continued service relationship.